Fed. Circ. Clears Perrigo's Generic Pepcid In Patent Case

The Federal Circuit ruled Thursday that Perrigo Co.'s generic version of the antacid Pepcid Complete does not infringe a patent owned by Boston's Brigham and Women's Hospital, ruling the evidence doesn't...

Already a subscriber? Click here to view full article